Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
87 articles
(Page 6)
Amivantamab Plus Chemotherapy: A New Frontline Treatment for NSCLC with EGFR Exon 20 Insertions
Study shows amivantamab-chemotherapy combo significantly improves outcomes in NSCLC with EGFR mutations
Durvalumab Boosts Survival in Early-Stage Lung Cancer
Study finds perioperative durvalumab plus chemotherapy improves outcomes in resectable NSCLC
Selpercatinib Outperforms Standard Treatment for Advanced Thyroid Cancer
Targeted RET inhibitor selpercatinib shows superior efficacy and safety in advanced thyroid cancer trial
Breakthrough Combo Therapy Shows Promise for Colorectal Cancer
New drug combination significantly improves outcomes for patients with advanced colorectal cancer
Immunotherapy Combo Boosts Survival in Advanced Bladder Cancer
Adding nivolumab to chemotherapy improves outcomes for patients with metastatic urothelial carcinoma
Erdafitinib Outperforms Chemo for Advanced Bladder Cancer with FGFR Mutations
Erdafitinib improves survival vs. chemo in metastatic urothelial cancer with FGFR alterations
Dual Immunotherapy Boosts Endometrial Cancer Outcomes
Durvalumab plus chemo followed by durvalumab +/- olaparib improves PFS in advanced endometrial cancer
Enzalutamide Improves Outcomes in High-Risk Prostate Cancer
Enzalutamide plus leuprolide or alone significantly delays metastasis in high-risk prostate cancer
Omega-3 Fatty Acids Fail to Prevent Paclitaxel-Induced Pain in Breast Cancer Patients
Study finds omega-3 supplements ineffective for preventing pain from paclitaxel chemotherapy in breast cancer
Aponermin Plus Standard Therapy Shows Promise for Relapsed Multiple Myeloma
Phase 3 trial finds aponermin combination improves outcomes in relapsed/refractory multiple myeloma patients
L-Glutamine: A Safe Supplement for Head and Neck Cancer Patients Undergoing Chemoradiotherapy
Study finds L-glutamine supplementation does not negatively impact survival in head and neck cancer patients
Oral Relugolix: A New Horizon in Prostate Cancer Treatment
Study shows oral relugolix has similar quality of life impact to leuprolide for prostate cancer patients